Jubilant Pharmova Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	12,676	10,883	9,564	10,139	9,838
Short-Term Investments	-	-	-	-	53.53
Cash & Short-Term Investments	12,676	10,883	9,564	10,139	9,892
Cash Growth	16.48%	13.79%	-5.67%	2.50%	43.48%
Accounts Receivable	10,696	10,043	10,134	10,508	9,914
Other Receivables	708	1,433	2,534	1,678	1,497
Receivables	11,423	11,487	12,676	12,197	11,426
Inventory	12,315	11,486	13,038	14,215	12,861
Prepaid Expenses	-	1,050	910	900	833.54
Other Current Assets	4,679	866	2,573	173	79.99
Total Current Assets	41,093	35,772	38,761	37,624	35,092
Property, Plant & Equipment	69,033	51,682	36,871	33,652	27,911
Long-Term Investments	614	435	422	2,564	2,386
Goodwill	28,261	25,410	24,639	24,286	22,428
Other Intangible Assets	12,766	10,967	10,433	9,510	9,263
Long-Term Deferred Tax Assets	2,571	2,574	2,327	2,275	1,613
Other Long-Term Assets	886	721	2,029	1,652	1,211
Total Assets	155,227	127,564	115,485	111,567	99,909
Accounts Payable	12,341	10,048	8,563	8,213	5,677
Accrued Expenses	-	3,947	3,293	2,786	3,091
Short-Term Debt	-	2,190	1,965	2,583	640
Current Portion of Long-Term Debt	2,478	676	505	414	3,994
Current Portion of Leases	670	556	521	534	521.93
Current Income Taxes Payable	201	184	370	624	345.06
Current Unearned Revenue	-	1,286	998	719	909.81
Other Current Liabilities	9,699	2,759	2,675	1,851	737.41
Total Current Liabilities	25,389	21,646	18,890	17,724	15,916
Long-Term Debt	29,717	21,503	31,671	31,104	24,642
Long-Term Leases	3,282	2,385	1,978	2,133	2,122
Long-Term Unearned Revenue	13,720	11,375	5,438	2,685	72.96
Pension & Post-Retirement Benefits	-	715	542	482	516.25
Long-Term Deferred Tax Liabilities	2,507	1,722	2,108	3,062	3,030
Other Long-Term Liabilities	9,656	5,832	647	459	445.45
Total Liabilities	84,271	65,178	61,274	57,649	46,745
Common Stock	158	158	158	159	159.28
Retained Earnings	-	53,018	45,397	45,368	46,860
Comprehensive Income & Other	70,770	9,373	8,784	8,466	6,166
Total Common Equity	70,928	62,549	54,339	53,993	53,186
Minority Interest	28	-163	-128	-75	-21.63
Shareholders' Equity	70,956	62,386	54,211	53,918	53,164
Total Liabilities & Equity	155,227	127,564	115,485	111,567	99,909
Total Debt	36,147	27,310	36,640	36,768	31,920
Net Cash (Debt)	-23,471	-16,427	-27,076	-26,629	-22,028
Net Cash Per Share	-147.72	-103.40	-170.44	-167.32	-138.39
Filing Date Shares Outstanding	158.06	158.4	158.35	159.07	159.17
Total Common Shares Outstanding	158.06	158.4	158.35	159.07	159.17
Working Capital	15,704	14,126	19,871	19,900	19,176
Book Value Per Share	448.75	394.89	343.16	339.43	334.14
Tangible Book Value	29,901	26,172	19,267	20,197	21,495
Tangible Book Value Per Share	189.18	165.23	121.67	126.97	135.04
Land	-	380	444	440	447.86
Buildings	-	7,459	8,622	8,498	7,957
Machinery	-	31,360	32,484	29,213	26,009
Construction In Progress	-	27,147	12,523	7,733	2,918

Source: S&P Global Market Intelligence. Standard template. Financial Sources.